Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study
…, GR Wilkinson, DB Clifford, RT D'Aquila… - The Journal of …, 2005 - academic.oup.com
BackgroundEfavirenz and nelfinavir are metabolized by cytochrome P-450 (CYP) 2B6 and
CYP2C19, respectively, with some involvement by CYP3A. Nelfinavir is a substrate for P-…
CYP2C19, respectively, with some involvement by CYP3A. Nelfinavir is a substrate for P-…
[HTML][HTML] Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection
…, RL Murphy, MI Becker, RT D'Aquila… - … England Journal of …, 2003 - Mass Medical Soc
Background The optimal sequencing of antiretroviral regimens for the treatment of infection
with human immunodeficiency virus type 1 (HIV-1) is unknown. We compared several …
with human immunodeficiency virus type 1 (HIV-1) is unknown. We compared several …
Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection: a randomized, double-blind, placebo-controlled …
RT D'Aquila, MD Hughes, VA Johnson… - Annals of internal …, 1996 - acpjournals.org
Objective: To study the addition of a third human immunodeficiency virus type 1 (HIV-1)
reverse transcriptase inhibitor, nevirapine, to the combination of zidovudine and didanosine. …
reverse transcriptase inhibitor, nevirapine, to the combination of zidovudine and didanosine. …
Cohabitation with a known Coronavirus disease 2019 case is associated with greater antibody concentration and symptom severity in a community-based sample of …
…, B Mustanski, EM McNally, R D'Aquila… - Open Forum …, 2021 - academic.oup.com
In a community-based sample of seropositive adults (n = 1101), we found that seropositive
individuals who lived with a known coronavirus disease 2019 (COVID-19) case exhibited …
individuals who lived with a known coronavirus disease 2019 (COVID-19) case exhibited …
Monitoring plasma HIV-1 RNA levels in addition to CD4+ lymphocyte count improves assessment of antiretroviral therapeutic response
…, N Basgoz, MA Fischl, RT D'Aquila - Annals of internal …, 1997 - acpjournals.org
Background: CD4+ lymphocyte counts and plasma HIV-1 RNA levels predict progression of
HIV-related disease, but the relative importance of these and other virological factors in …
HIV-related disease, but the relative importance of these and other virological factors in …
[HTML][HTML] Durability of antibody response to vaccination and surrogate neutralization of emerging variants based on SARS-CoV-2 exposure history
…, A Sancilio, B Mustanski, RT D'Aquila… - Scientific reports, 2021 - nature.com
Two-dose messenger RNA vaccines against the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are highly effective in preventing symptomatic COVID-19 infection. …
coronavirus 2 (SARS-CoV-2) are highly effective in preventing symptomatic COVID-19 infection. …
[HTML][HTML] High seroprevalence for SARS-CoV-2 among household members of essential workers detected using a dried blood spot assay
Objective Serological testing is needed to investigate the extent of transmission of SARS-CoV-2
from front-line essential workers to their household members. However, the requirement …
from front-line essential workers to their household members. However, the requirement …
[HTML][HTML] Comparison of four-drug regimens and pairs of sequential three-drug regimens as initial therapy for HIV-1 infection
…, V De Gruttola, SW Snyder, RT D'Aquila… - … England Journal of …, 2003 - Mass Medical Soc
Background It is unclear whether therapy for human immunodeficiency virus type 1 (HIV-1)
should be initiated with a four-drug or two sequential three-drug regimens. Methods In this …
should be initiated with a four-drug or two sequential three-drug regimens. Methods In this …
Preferences for long-acting pre-exposure prophylaxis (PrEP), daily oral PrEP, or condoms for HIV prevention among US men who have sex with men
HIV prevention method preferences were evaluated among 512 US men who have sex with
men (MSM; median age: 22 years). Approximately 90 % consistently preferred one option …
men (MSM; median age: 22 years). Approximately 90 % consistently preferred one option …
[HTML][HTML] A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples
AE Sancilio, RT D'Aquila, EM McNally, MP Velez… - Scientific reports, 2021 - nature.com
The spike protein of SARS-CoV-2 engages the human angiotensin-converting enzyme 2 (ACE2)
receptor to enter host cells, and neutralizing antibodies are effective at blocking this …
receptor to enter host cells, and neutralizing antibodies are effective at blocking this …